Global animal model market is set to gain massive momentum over the estimated timeframe of 2020 to 2026. This can be credited to accelerating product demand owing to ongoing pharmaceutical research and development activities across the globe. Additionally, increasing prevalence of chronic disorders such as cardiovascular diseases, atherosclerosis, and hypertension has evoked the demand for development of therapeutic drugs which has further instigated the adoption of animal models. For instance, Novo Nordisk utilizes live animals for drug research and development of new products.
Contract research organizations (CROs) are nowadays being approach by the pharma firms to outsource their research activities and save on production time and cost. Animal models are experiencing a substantial rise in adoption across various CROs. Earlier in 2019, the segment had attained a valuation of almost USD 1,111 million. Apart from human drugs, CROs also support the development of veterinary drugs and handle a range of tasks like toxicology studies and clinical trials.
Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/4435
With regards to animal type, pig model segment is expected to register substantial gains over the upcoming years owing to heightened product adoption due to large similarity between the immune systems and physiology of pigs and that of humans. Reportedly, there is almost 80% resemblance in porcine and human immune system which make pigs a reliable and suitable animal model for developing intranasal vaccine formulations for humans.
Considering the application spectrum, preclinical segment is estimated to expand at a significant CAGR of 8.5% over the analysis time period considering the rising prevalence of several human disorders, stimulating the need for preclinic evaluation of novel therapeutic drugs. These preclinical processes extensively use animal models for drug discovery as well as small molecules and biologics. For instance, usage of humanized mouse models in preclinical translational research related to in vivo human immune system has shown notable progress in recent years.
Based on technology bifurcation, CRISPR recorded an appreciable valuation of USD 4,697 million in 2019 and is anticipated to grow over time, given its increased adoption as it enables rapid generation of new mouse models and is cost-effective. For example, CRISPR-Cas9 technology produced rat models which are being used for developing effective therapeutic procedures. Besides, it is used in knock-in and knockout mice which is important for research of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and Huntington disease.
Considering the regional landscape, South Korea is estimated to emerge as a strong growth avenue for animal model market with a substantial growth rate of 10.7% through 2026. This growth can be attributed to increasing cosmetic surgeries and several other therapies across the region. Speaking of which animal models are witnessing increased demand from research institutes in the country driven by rising need for testing safety and efficacy of cosmetic drugs.
Major players operating in the animal model market such as Envigo, Charles River, genOway, The Jackson Laboratory, Harbour BioMed, Janvier Labs, Taconic Biosciences Inc., etc. have been implementing various strategic initiatives such as new product launch, mergers and acquisitions for gaining a competitive edge in the market.
Request for customization @ https://www.gminsights.com/roc/4435
Partial Chapter of the Table of Content
Chapter 5 Animal Model Market, By Technology
5.1 Key segment trends
5.2.1 Animal Model Market size, by region, 2015 – 2026 (USD Million)
5.3.1 Market size, by region, 2015 – 2026 (USD Million)
5.4 Embryonic Stem Cell Injection
5.4.1 Market size, by region, 2015 – 2026 (USD Million)
5.5 Nuclear Transfer
Charts & Figures
FIG. 1 Bottom-up analysis (demand side analysis)
FIG. 2 Data validation
FIG. 3 Animal model market 3600 synopsis
FIG. 4 Industry segmentation
FIG. 5 Global animal model market size, 2015 -2026 (USD Million)
FIG. 6 Growth potential analysis, by animal type
FIG. 7 Growth potential analysis, by technology
FIG. 8 Growth potential analysis, by application
FIG. 9 Growth potential analysis, by use
FIG. 10 Growth potential analysis, by end-use
FIG. 11 Porter’s analysis
FIG. 12 Company matrix analysis
FIG. 13 PESTEL analysis
FIG. 14 Key segment trends, by animal type
FIG. 15 Key segment trends, by technology
FIG. 16 Key segment trends, by application
Browse full table of contents (TOC) of this report @ https://www.gminsights.com/toc/detail/animal-model-market